Corporate Corruption Media Articles

Excerpts of Key Corporate Corruption Media Articles in Major Media

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.

In school, Anas Mohammadu's mates call him "horror" and make fun of him. But Anas is lucky to be alive. Other children who were used in the controversial 1996 drug trial by US pharmaceutical giant Pfizer died. Anas, then only three years old, was the first child to be given the experimental antibiotic Trovan at the Infectious Diseases Hospital, Kano, during the drug trial. Pfizer tested the then unregistered drug in Nigeria's north-western Kano State during an outbreak of meningitis which had affected thousands of children. Officials in Kano say more than 50 children died in the experiment, while many others developed mental and physical deformities. But Pfizer says only 11 of the 200 children used in the drug trial died. Following pressure from rights groups and families affected by the trial, the Nigerian government set up an expert medical panel to review the drug trial. The experiment was "an illegal trial of an unregistered drug", the Nigerian panel concluded, and a "clear case of exploitation of the ignorant". After more than a decade of silence, the Nigerian government has decided to sue Pfizer, seeking $7bn (Ł3.5bn) in damages for the families of children who allegedly died or suffered side-effects in the experiment. Kano State government has also filed separate charges against Pfizer.

Note: Pfizer settled the case out of court, as reported by BBC at this link.

As states begin to require that drug companies disclose their payments to doctors for lectures and other services, a pattern has emerged: psychiatrists earn more money from drug makers than doctors in any other specialty. How this money may be influencing psychiatrists and other doctors has become one of the most contentious issues in health care. For instance, the more psychiatrists have earned from drug makers, the more they have prescribed a new class of powerful medicines known as atypical antipsychotics to children, for whom the drugs are especially risky and mostly unapproved. Vermont officials disclosed Tuesday that drug company payments to psychiatrists in the state more than doubled last year, to an average of $45,692 each from $20,835 in 2005. Antipsychotic medicines are among the largest expenses for the state’s Medicaid program. Over all last year, drug makers spent $2.25 million on marketing payments, fees and travel expenses to Vermont doctors, hospitals and universities, a 2.3 percent increase over the prior year, the state said. The number most likely represents a small fraction of drug makers’ total marketing expenditures to doctors since it does not include the costs of free drug samples or the salaries of sales representatives and their staff members. According to their income statements, drug makers generally spend twice as much to market drugs as they do to research them. Endocrinologists received the second largest amount, according to the Vermont analysis, earning an average of $33,730. Since the state identified the specialties of only the top 100 earners, these averages represent the money earned by only some of the state’s specialists. There were 11 psychiatrists and 5 endocrinologists in that top group of 100.

Note: For much more reliable, verifiable information on corruption in the pharmaceutical industry, click here.

Opponents of GE [genetically engineered] food ... say problems suggested in some health studies could take years to show up. Meanwhile, we're eating lots of GE foods anyway, whether we know it or not -- especially in processed foods, because corn, soy and canola are the Big 3 GE food crops." Since our government has refused to label these foods, how do we avoid buying and eating these foods?" asks [Andrew] Kimbrell, an attorney who heads the Washington, D.C.-based Center for Food Safety, a vocal opponent of GE foods. His new book, Your Right to Know: Genetic Engineering and the Secret Changes in Your Food ... answers that question. For conscious eaters, the heart of the book is a 14-page guide to your local supermarket. It tells you which foods are the most likely to contain GE ingredients (chips, snacks and baby formula), which aren't (fruits, vegetables, wheat), and how to read labels for "hidden ingredients" derived from corn, soy or canola (hint: look for high fructose corn syrup, soy lecithin and canola oil). A passport-size version of the guide, small enough to slide into most pockets or purses, comes along with the book. "I wanted to give people a usable tool to avoid these foods so they don't feel so helpless," said Kimbrell. The book isn't intended to present the pros and cons of GE foods. Kimbrell is 100 percent against the technology and spends a lot of time in court fighting companies like Monsanto, to keep GE crops from spreading. The Center for Food Safety also opposes irradiation and food animal cloning, and has labored to keep industry from weakening federal organic standards. In fact, Kimbrell is the man who calls the current administration's efforts to protect food safety "Katrina on a plate."

Ken Silverstein says he lied, deceived and fabricated to get the story. But it was worth it, he insists. Those on the receiving end don't agree. As Washington editor of Harper's magazine, Silverstein posed as Kenneth Case, a London-based executive with the fictional Maldon Group, claiming to represent the government of Turkmenistan. He had fake business cards printed, bought a London cellphone number and created a bogus Web site -- all to persuade Beltway lobbying firms to pitch him on representing Turkmenistan. "For me to deny, or try to shade the fact that I tricked them would be stupid," Silverstein says. "Obviously we did. If our readers feel uncomfortable, they're free to dismiss the findings of the story." Says Harper's Editor Roger Hodge: "The big question in our mind was whether anybody was going to fall for it." They did. According to Harper's, executives at the Washington firm APCO Worldwide laid out a communications plan that included lobbying policymakers -- possibly including a trip for members of Congress -- and generating "news items." Senior Vice President Barry Schumacher told Silverstein the firm could drum up positive op-ed pieces by utilizing certain think tank experts. The proposed fee: $40,000 a month. Another Washington firm, Cassidy & Associates, asked for at least $1.2 million a year and touted a proposed trip to Turkmenistan for journalists and think tank analysts. Hodge says the caper is part of "a long history of sting operations" by journalists. But that undercover tradition has faded in recent years. No newspaper today would do what the Chicago Sun-Times did in the 1970s, setting up a bar to entrap crooked politicians. Fewer television programs are doing what ABC did in the 1990s, having producers lie to get jobs at a supermarket chain to expose unsanitary practices.

Note: To read the hard-hitting, in-depth article in Harper's magazine, click here.

The U.S. Department of Agriculture gave interim approval Friday to a controversial proposal to allow 38 nonorganic ingredients to be used in foods carrying the "USDA Organic" seal. Manufacturers of organic foods had pushed for the change, arguing that the 38 items are minor ingredients in their products and are difficult to find in organic form. But consumers opposed to the use of pesticides, chemical fertilizers, antibiotics and growth hormones in food production bombarded the USDA with more than 1,000 complaints last month. "If the label says organic, everything in that food should be organic," wrote Kimberly Wilson of Austin, Texas, in one typical comment. "If they put something in the food that isn't organic, they shouldn't be able to call it organic. No exception." The list approved Friday includes 19 food colorings, two starches, hops, sausage casings, fish oil, chipotle chili pepper, gelatin, celery powder, dill weed oil, frozen lemongrass, Wakame seaweed, Turkish bay leaves and whey protein concentrate. Manufacturers will be allowed to use conventionally grown versions of these ingredients in foods carrying the USDA seal, provided that they can't find organic equivalents and that nonorganics comprise no more than 5% of the product. A wide range of organic food could be affected, including cereal, sausage, bread, beer, pasta, candy and soup mixes. The Organic Consumers Assn. ... has led the opposition to the USDA proposal. Ronnie Cummins, executive director of the consumers group, said ... that the USDA was caving in to pressure from large food companies. USDA officials "don't seem to care what the public wants. They're just more interested in what's convenient for the big companies."

The knee-jerk attitude that the U.S. is the best place on earth to be sick, fueled by the reputations of great institutions like the Mayo Clinic and by America's leadership in drug and technology development, is beginning to be challenged by rigorous international comparisons. There is increasing evidence that, despite justified pride in individual institutions and medical breakthroughs, the world's biggest medical spender isn't buying its citizens the longest, healthiest lives in the world. It's not just moviemakers and comics saying so. The dire message that the U.S. healthcare system is, by some measures, an also-ran on the worldwide stage is being delivered by doctors, researchers — even insurance industry giants. On screen, slamming U.S. medical care is coming of age with Michael Moore's documentary "Sicko." Through the eyes of people who have faced healthcare catastrophes, he tells graphic stories of the problems with America's system. Considerably more sobering are the warnings from an official at the National Institutes of Health, who declared in the May 16 issue of the Journal of the American Medical Assn. that the U.S. healthcare system is "a dysfunctional mess." Amid stacks of reports, all with ... measures of access, equity, efficiency and medical outcomes, two statistics stand out. The U.S. spends more on medical care than any other nation, and gets far less for it than many countries. The U.S. spends an annual $6,102 per person — more than any other country and more than twice the average of $2,571. Yet Americans have the 22nd highest life expectancy among those nations at 77.2 years. People in Japan, the world leader in longevity, live an average of 81.8 years.

A congressional task force called Thursday for a speedy resolution to a southwest Florida election dispute that questions the accuracy of ATM-style voting machines. Democrat Christine Jennings claims that touch-screen voting machines in Sarasota County failed to register up to 18,000 votes. Republican Vern Buchanan was declared the winner by 369 votes after two recounts and a state audit found no problems. GAO investigators will gather information on Sarasota County's voting systems, analyze the 18,000 so-called ''undervotes,'' review tests and audits done after the election and determine if more tests are needed. Jennings said Thursday the she was pleased even though the approach brings her no closer to gaining access to hardware and software that the machines' maker, Omaha, Neb.-based Election Systems & Software Inc., says is a trade secret.

Note: The software in electronic voting machines is considered proprietary information, kept secret from Congress, the courts and even the President. Yet any computer programmer will tell you that this software can be manipulated. To join in demanding transparency in our elections process, contact your political representatives by clicking here. For more reliable information on this issue vital to democracy, click here.

Allies of the U.S. auto industry stepped up a campaign yesterday to soften strict vehicle fuel-efficiency mandates in proposed energy legislation before the Senate, even as momentum for the tougher measures continued to build. Auto lobbyists said they were encountering stiff resistance on Capitol Hill. They said they felt like the industry was being punished for what one called the "sins of the past" -- successfully beating back attempts to make major changes to the nation's vehicle mileage laws. Yesterday, Sen. Dianne Feinstein (D-Calif.) defended the current bill, arguing that it would provide flexibility for automakers. "There are all kinds of dire warnings," Feinstein said. "The fact of matter is that Detroit has done nothing about mileage efficiency for the past 20 years, and the time has come."

Note: It is also worth noting that Congress itself has done nothing to mandate higher fuel efficiency in cars over the last twenty years. For a highly revealing article showing that while other industries have had many major breakthroughs and huge technological advances over the decades, automobile makers for some strange reason have been unable to improve car mileage since the days of the Model T, click here.

The revelation that the diabetes drug Avandia can potentially cause heart disease is the latest in a string of pharmaceutical disappointments. Vioxx was pulled from the market in 2004 because it doubled the risks for heart attacks and strokes. Eli Lilly recently paid $750 million to settle lawsuits alleging that Zyprexa causes diabetes. Many have criticized the Food and Drug Administration as being too lax about monitoring drug safety. While those criticisms have merit, there is another culprit: the transformation of continuing medical education into an enterprise for drug marketing. The chore of teaching doctors how to practice medicine has been handed to the pharmaceutical industry. As a result, dangerous side effects are rarely on the curriculum. Most states require that doctors obtain a minimum number of credit hours of continuing medical education each year to maintain their medical licenses. Not so long ago, most of these courses were produced and paid for by universities and medical associations. But this has changed drastically over the past decade. Drug-industry financing of continuing medical education has nearly quadrupled since 1998, from $302 million to $1.12 billion. Half of all continuing medical education courses in the United States are now paid for by drug companies, up from a third a decade ago. Because pharmaceutical companies now set much of the agenda for what doctors learn about drugs, crucial information about potential drug dangers is played down, to the detriment of patient care. For example, GlaxoSmithKline footed the bill for dozens of educational courses intended to emphasize the benefits of Avandia over other drugs.

Note: For a concise, reliable overview of medical corruption, click here.

In April 1971, CIA officer John Seabury Thomson paddled his aluminum canoe across the Potomac on his daily commute from his home in Maryland to CIA headquarters in Langley. When he reached the Virginia shore, he noticed a milky substance clouding the waters around Pulp Run. A fierce environmentalist, Thomson traced the pollution to its source: his employer. The murky white discharge was a chemical mash, the residue of thousands of liquefied secrets that the agency had been quietly disposing of in his beloved river. He single-handedly brought the practice to a halt. Nearly four decades later, though, that trickle of secrets would be a tsunami that would capsize Thomson's small craft. Today the nation's obsession with secrecy is redefining public and private institutions and taking a toll on the lives of ordinary citizens. Excessive secrecy is at the root of multiple scandals -- the phantom weapons of mass destruction, the collapse of Enron, the tragedies traced to Firestone tires and the arthritis drug Vioxx, and more. In this self-proclaimed "Information Age," our country is on the brink of becoming a secretocracy, a place where the right to know is being replaced by the need to know. [There] is a confluence of causes behind it, among them the chill wrought by 9/11, industry deregulation, the long dominance of a single political party, fear of litigation and liability and the threat of the Internet. But perhaps most alarming [is] the public's increasing tolerance of secrecy. Without timely information, citizens are reduced to mere residents, and representative government atrophies into a representational image of democracy as illusory as a hologram.

Note: The author of this superb article is Ted Gup. He is a journalism professor at Case Western Reserve University and author of Nation of Secrets: The Threat to Democracy and the American Way of Life.

Many beer drinkers may not know that Anheuser-Busch has the organic blessing from federal regulators even though Wild Hop Lager uses hops grown with chemical fertilizers and sprayed with pesticides. The [USDA] is considering a list of 38 nonorganic ingredients that will be permitted in organic foods. Because of the broad uses of these ingredients — as colorings and flavorings, for example — almost any type of manufactured organic food could be affected, including cereal, sausage, bread and beer. Organic food advocates have fought to block approval of some or all of the proposed ingredients, saying consumers would be misled. "This proposal is blatant catering to powerful industry players who want the benefits of labeling their products 'USDA organic' without doing the work to source organic materials," said Ronnie Cummins, executive director of the Organic Consumers Assn. of Finland, Minn., a nonprofit group that boasts 850,000 members. With big companies entering what was formerly a mom-and-pop industry, new questions have arisen about what exactly goes into organic food. Many nonorganic ingredients, including hops, are already being used in organic products, thanks to a USDA interpretation of the Organic Foods Protection Act of 1990. In addition to hops, the list includes 19 food colorings, two starches, casings for sausages and hot dogs, fish oil, chipotle chili pepper, gelatin and a host of obscure ingredients (one, for instance, is a "bulking agent" and sweetener with the tongue-twisting name of fructooligosaccharides). Under the agency's proposal, as much as 5% of a food product could be made with these ingredients and still get the "USDA organic" seal.

Peter Rost is worked up. The ex-Pfizer senior executive turned blogger believes he has uncovered another instance of unethical marketing by Big Pharma. Rost's blog, Question Authority With Dr. Rost, is one part mocking rant, two parts investigative chronicle. He has also published an exposé of his years in the drug industry, "The Whistleblower: Confessions of a Healthcare Hitman." Trained as a physician in his native Sweden, Rost has worked in the drug industry for most of the past 20 years. He almost certainly never will again. Rost hopes that Question Authority - named after the Fortune column in which he was once featured - will help him create a new career. Rost's many critics would love to be able to dismiss him as an embittered crank. But they can't. The blog [is] a conduit for Big Pharma whistleblowers [that once prompted] a government probe into Pfizer's marketing activities. And a dispatch on dubious sales practices led to at least one sales director's ouster. For Big Pharma, whose public image is already battered, blogs are an added nuisance. The problem, says Robert Ehrlich, CEO of DTC Perspectives, a health-care marketing consultancy, is that most pharma companies are, "medically oriented and legally oriented ... but as an industry they are not consumer-oriented." For better or worse, the drug industry is going to have to get used to Dr. Peter Rost - and others like him.

Note: Read an excellent article on Dr. Rost and other major whistleblowers from the pharmaceutical industry. For more along these lines, see concise summaries of deeply revealing big pharma corruption news articles from reliable major media sources.

Money talks -- and very loudly -- when a drug company is funding a clinical trial involving one of its products. UCSF researchers looked at nearly 200 head-to-head studies of widely prescribed cholesterol-lowering medications, or statins, and found that results were 20 times more likely to favor the drug made by the company that sponsored the trial. "We have to be really, really skeptical of these drug-company-sponsored studies," said Lisa Bero, the study's author and professor of clinical pharmacy and health policy studies. The trials typically involved comparing the effectiveness of a drug to one or two other statins. UCSF researchers also found that a study's conclusions -- not the actual research results but the trial investigators' impressions -- are more than 35 times more likely to favor the test drug when that trial is sponsored by the drug's maker. Bero said drug companies fund up to 90 percent of drug-to-drug clinical trials for certain classes of medication. The researchers found other factors that could affect trial results. For example, pharmaceutical companies could choose not to publish results of studies that fail to favor their drugs, or they could be designed in ways to skew results. The study found the most important weakness of trials was lack of true clinical outcome measures. In the case of statins, some trials focused on less-direct results such as lipid levels but failed to connect the results with key outcomes such as heart attacks or mortality. "None of us really care what our cholesterol level is. We care about having a heart attack," Gibson said. "For the drug to be worthwhile taking, it has to be directly related to prevent a heart attack."

Note: For lots more reliable information about corruption in the pharmaceutical industry, click here.

They might be called China’s renegade businessmen, small entrepreneurs who are experts at counterfeiting and willing to go to extraordinary lengths to make a profit. But just how far out of the Chinese mainstream are they? Cutting corners or producing fake goods is not just a legacy of China’s initial rush toward the free market three decades ago but [is] still woven into the fabric of the nation’s thriving industrial economy. It is driven by entrepreneurs who are taking advantage of a weak legal system, lax regulations and a business culture where bribery and corruption are rampant. “This is cut-throat market capitalism,” said Wenran Jiang, a specialist in China who teaches at the University of Alberta. Since this country’s economic reforms began to take root in the 1980s, businesses have engineered countless ways to produce everything from fake car parts, cosmetics and brand name bags to counterfeit electrical cables and phony Viagra. Counterfeiting rings are broken nearly every week; nonetheless, the government seems to be waging a losing battle against the operations. Dozens of Chinese cities have risen to prominence over the last two decades by first specializing in fake goods, like Wenzhou, which was once known for selling counterfeit Procter & Gamble products, and Kaihua in Zhejiang province, which specialized in fake Philips light bulbs. For a time, people even derided the entire province of Henan as the capital of substandard or fake goods, like medicines that could make you miraculously grow taller.

Note: The fact that China recently sentenced to death the former head of the State Food and Drug Administration may show that China is trying to address the problem, yet corruption is rampant in the drug industries of China, the U.S., and most other countries.

Within a few hours, Cynthia Kline was dead. She died in an American city with one of the highest concentrations of top-flight medical specialists in the world. And it happened largely because of America's broken health care system - one where 50 million people are entirely without insurance coverage and tens of millions more struggle to have the treatment they need approved. As a result, medical problems go unattended until they reach crisis point. America's health system offers a tremendous paradox. In medical technology and in the scientific understanding of disease, it is second-to-none. And yet many, if not most, Americans are unable to reap the advantages of this. In fact, as The New York Times columnist Paul Krugman has argued, the very proliferation of research and high-tech equipment is part of the reason for the imbalance in coverage between the privileged few and the increasingly underserved masses. "[The system] compensates for higher spending on insiders, in part, by consigning more people to outsider status --robbing Peter of basic care in order to pay for Paul's state-of-the-art treatment," Krugman wrote. "Thus we have the cruel paradox that medical progress is bad for many Americans' health." Having the system run by for-profit insurance companies turns out to be inefficient and expensive as well as dehumanising. America spends more than twice as much per capita on health care as France, and almost two and a half times as much as Britain. And yet it falls down in almost every key indicator of public health, starting ... with infant mortality, which is 36 per cent higher than in Britain.

[A new] study ... finds that not only is the U.S. health care system the most expensive in the world (double that of the next most costly comparator country, Canada) but comes in dead last in almost any measure of performance. Although U.S. political leaders are fond of stating that we have the best health-care system in the world, they fail to acknowledge an important caveat: It is the best only for the very rich. For the rest of the population, its deficits far outweigh its advantages. [The] study compared the United States with Australia, Canada, Germany, New Zealand and the United Kingdom. Although the most notable way in which the United States differs from the other countries is in the absence of universal coverage, the United States is also last on dimensions of access, patient safety, efficiency and equity. The other five countries considered spend considerably less on health care, both per capita and as a percent of gross domestic product, than the United States. The United States spends $7,000 per person per year on health care, almost double that of Australia, Canada and Germany, each of which achieve better results on health status indicators than the United States. The United States also lags behind all industrialized nations in terms of health coverage. 46.6 million Americans (about 15.9 percent of the population) had no health insurance coverage during 2005. It is no wonder, then, that medical bills are overwhelmingly the most common reason for personal bankruptcy in the United States.

Note: For a treasure trove of reliable information on health, click here.

If you pop a vitamin C tablet in your mouth, it's a good bet it came from China. Indeed, many of the world's vitamins are now made in China. In less than a decade, China has captured 90 percent of the U.S. market for vitamin C, driving almost everyone else out of business. Chinese pharmaceutical companies also have taken over much of the world market in the production of antibiotics, analgesics, enzymes and primary amino acids. According to an industry group, China makes 70 percent of the world's penicillin, 50 percent of its aspirin and 35 percent of its [Tylenol], as well as the bulk of vitamins A, B12, C and E. In the wake of a pet-food scandal, in which adulterated wheat gluten from China led to the deaths of thousands of pets in North America, and other instances of food and toothpaste tampering, China's vitamin producers are reaching out to reassure U.S. consumers that their vitamins are safe. Whether that's true isn't clear, however. Foreign food-safety experts say China's larger companies have reputations to protect. The question is how they maintain quality control. Since U.S. laws don't require food and drug sellers to label products with the country of origin of ingredients, it's impossible for consumers to know where food or supplements are coming from, not to mention what factory produced them.

The Bush administration said Tuesday it will fight to keep meatpackers from testing all their animals for mad cow disease. The Agriculture Department tests less than 1 percent of slaughtered cows for the disease, which can be fatal to humans who eat tainted beef. But Kansas-based Creekstone Farms Premium Beef wants to test all of its cows. Larger meat companies feared that move because, if Creekstone tested its meat and advertised it as safe, they might have to perform the expensive test, too. The Agriculture Department regulates the test and argued that widespread testing could lead to a false positive that would harm the meat industry. A federal judge ruled in March that such tests must be allowed. U.S. District Judge James Robertson noted that Creekstone sought to use the same test the government relies on and said the government didn't have the authority to restrict it. The ruling was to take effect June 1, but the Agriculture Department said Tuesday it would appeal -- effectively delaying the testing until the court challenge plays out. Mad cow disease, or bovine spongiform encephalopathy, is linked to more than 150 human deaths worldwide, mostly in Britain. There have been three cases of mad cow disease in the U.S.

By Dr. Michael Wilkes. When is a disease really a disease? Young doctors in training work hard, and so do lots of other people. When people work 24 hours in a row ... the body feels tired. Is this fatigue an abnormal physiologic state requiring medication and treatment, or is it a normal part of belonging to the human race? If abnormal, then doctors and pharmaceutical companies argue that the fatigue requires treatment. If it is normal -- despite a movement to label it as an illness -- then post-work fatigue belongs to the growing phenomenon of disease-mongering. "Disease-mongering" ... is the process of trying to convince healthy people that they are sick, or people with minor problems that they have extremely worrisome symptoms. This is all in an attempt to sell treatments. Countless examples of disease-mongering are driven by the pharmaceutical industry's drive to sell drugs. Conditions such as female sexual dysfunction syndrome, premenstrual dysphoric disorder, toenail fungus, baldness and social anxiety disorder (a.k.a. shyness) are a few places where the medical community has stepped in, thereby turning normal or mild conditions into diseases for which medication is the treatment. Most pharmaceutical companies devote huge amounts of money to prevent, control and cure diseases. When their profits don't match corporate expectations, they invent "new" diseases to be cured by existing drugs. What happens to real diseases when [the media] are filled with information promoting disease mongering? Government funding for public health campaigns pales by comparison with the billions spent by pharmaceutical companies on disease mongering intended to increase the markets for their products.

Note: For more reliable information about major corruption in the pharmaceutical industry, click here.

What Ray Anderson calls his “conversion experience” occurred in the summer of 1994, when he was asked to give the sales force at Interface, the carpet tile company he founded, some talking points about the company’s approach to the environment. So he started reading about environmental issues, and thinking about them, until pretty soon it hit him: “I was running a company that was plundering the earth,” he realized. “I thought, ‘Damn, some day people like me will be put in jail!’” He devoted his speech to his newfound vision of polluted air, overflowing landfills, depleted aquifers and used-up resources. Only one institution was powerful enough and pervasive enough to turn these problems around, he told his colleagues, and it was the institution that was causing them in the first place: “Business. Industry. People like us. Us!" He challenged his colleagues to set a deadline for Interface to become a “restorative enterprise,” a sustainable operation that takes nothing out of the earth that cannot be recycled or quickly regenerated, and that does no harm to the biosphere. The deadline they ultimately set is 2020, and the idea has taken hold throughout the company. Mr. Anderson said that through waste reduction, recycling, energy efficiency and other steps, Interface was “about 45 percent from where we were to where we want to be.” Use of fossil fuels is down 45 percent ... he said, while sales are up 49 percent. Globally, the company’s carpet-making uses one-third the water it used to. The company’s worldwide contribution to landfills has been cut by 80 percent. And in the process, Mr. Anderson has turned into perhaps the leading corporate evangelist for sustainability.

Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.